Insights

Growth momentum Repligen reported strong revenue growth with a 16% increase to 738 million in 2025 and quarterly results showing continued profitability and scale, indicating a ripe market for expanded bioprocessing solutions and higher capacity deployments.

Capacity expansion The opening of the Breda European Training & Innovation Center and the OPUS pre-packed chromatography columns facility demonstrates ongoing capacity growth and regional support expansion, signaling opportunities for localized service contracts, training, and advanced resin and column components.

Gene therapy focus Product launches such as AVIPure affinity resins and HiPerT anion-exchange resins targeted at gene therapy and viral vector purification suggest a strategic emphasis on vector purification solutions suitable for customers pursuing cell and gene therapies and related modalities.

Integrated workflows Repligen’s portfolio across filtration, chromatography systems, analytics, and fluid management positions it well to offer end-to-end bioprocessing improvements, enabling cross-sell opportunities to biomanufacturers seeking integrated systems and single-vendor efficiency.

Global support With 22 sites worldwide and a broadened European training network, there is a clear opportunity to upsell regional service agreements, on-site training, and certified maintenance programs to biopharma manufacturers expanding manufacturing footprints globally.

Similar companies to Repligen Corporation

Repligen Corporation Tech Stack

Repligen Corporation uses 8 technology products and services including IBM Cognos Analytics, Canva, Apache Spark, and more. Explore Repligen Corporation's tech stack below.

Media & News

Repligen Corporation's Email Address Formats

Repligen Corporation uses at least 3 email formats:
Repligen Corporation Email FormatsExamplePercentage
FLast@repligen.comJDoe@repligen.com
91%
LFirst@repligen.comDJohn@repligen.com
8%
LastFirst@repligen.comDoeJohn@repligen.com
1%

Frequently Asked Questions

What is Repligen Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Repligen Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Repligen Corporation's stock symbol?

Minus sign iconPlus sign icon
Repligen Corporation is a publicly traded company; the company's stock symbol is RGEN.

What is Repligen Corporation's official website and social media links?

Minus sign iconPlus sign icon
Repligen Corporation's official website is repligen.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Repligen Corporation generate?

Minus sign iconPlus sign icon
As of October 2026, Repligen Corporation's annual revenue is estimated to be $500M - $1B.

What is Repligen Corporation's SIC code and NAICS code?

Minus sign iconPlus sign icon
Repligen Corporation's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Repligen Corporation have currently?

Minus sign iconPlus sign icon
As of October 2026, Repligen Corporation has approximately 1.5K employees across 5 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer Director: B. M., Chief Financial Officer: J. G. and Vice President R&d: L. M. Explore Repligen Corporation's employee directory with LeadIQ.

What industry does Repligen Corporation belong to?

Minus sign iconPlus sign icon
Repligen Corporation operates in the Biotechnology Research industry.

What technology does Repligen Corporation use?

Minus sign iconPlus sign icon
Repligen Corporation's tech stack includes IBM Cognos Analytics, Canva, Apache Spark, Microsoft Active Directory, Microsoft Entra ID, ZoomInfo, Bitbucket and Citrix.

What is Repligen Corporation's email format?

Minus sign iconPlus sign icon
Repligen Corporation's email format typically follows the pattern of FLast@repligen.com. Find more Repligen Corporation email formats with LeadIQ.

How much funding has Repligen Corporation raised to date?

Minus sign iconPlus sign icon
As of October 2026, Repligen Corporation has raised $1.3B in funding. The last funding round occurred on Dec 06, 2023 for $600M.
Repligen Corporation logo

Repligen Corporation

Biotechnology ResearchMassachusetts, United States1001-5000 Employees

Repligen is a global biotechnology company focused on bioprocessing technologies that support the development and manufacture of biologics. Its offerings span filtration, chromatography systems, process analytics, fluid management, and proteins, providing tools to enable efficient manufacturing workflows. Its customer base includes developers and manufacturers of a broad range of biologics—cell and gene therapies, mRNA products, monoclonal antibodies, antibody–drug conjugates, bispecific antibodies, and fusion proteins—who rely on its solutions throughout development and production.

Headquartered in Waltham, Massachusetts, Repligen operates across 22 sites worldwide, with a presence in the United States, Europe, and the Asia-Pacific region. In April 2026, the company opened a Training & Innovation Center at its Breda facility in Western Europe, expanding its European customer support network.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
RGEN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $1.3B

    Repligen Corporation has raised a total of $1.3B of funding over 6 rounds. Their latest funding round was raised on Dec 06, 2023 in the amount of $600M as a Post IPO Debt.

  • $500M - $1B

    Repligen Corporation's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.